- Filed
- Mar 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 31, 2025 | 38.3M sh |
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $126.12K |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $185.68K |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $204.44K |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $166.46K |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $300.84K |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $249.95K |
| Current Assets | Q1 2025 · Jan 31, 2025 | $1.18M |
| Current Assets | Q1 2025 · Oct 31, 2024 | $1.01M |
| Total Assets | Q1 2025 · Jan 31, 2025 | $1.86M |
| Total Assets | Q1 2025 · Oct 31, 2024 | $1.69M |
| Shares Diluted | Q1 2025 · Jan 31, 2024 | 38.05M sh |
| Operating Cash Flow restated | Q1 2025 · Jan 31, 2024 | −$122.86K |
| Sga Expense | Q1 2025 · Jan 31, 2024 | $85.68K |
| Net Income restated | Q1 2025 · Jan 31, 2024 | −$44.73K |
| Operating Income | Q1 2025 · Jan 31, 2024 | −$54.62K |
| Revenue | Q1 2025 · Jan 31, 2024 | $65.89K |